Pages that link to "Q34756317"
Jump to navigation
Jump to search
The following pages link to Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis (Q34756317):
Displaying 13 items.
- Hepatic inflammation and fibrosis: functional links and key pathways (Q35213917) (← links)
- Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice (Q35481673) (← links)
- Toll-like receptor 7 affects the pathogenesis of non-alcoholic fatty liver disease (Q36986160) (← links)
- Early to Phase II drugs currently under investigation for the treatment of liver fibrosis (Q38303313) (← links)
- HRS plays an important role for TLR7 signaling to orchestrate inflammation and innate immunity upon EV71 infection (Q40064931) (← links)
- IFNL4 rs368234815 TT>δG Variant is Associated with Liver Damage in Patients with Non-alcoholic Fatty Liver Disease (Q40121061) (← links)
- Hepatocyte mitochondrial DNA released in microparticles and toll-like receptor 9 activation: A link between lipotoxicity and inflammation during nonalcoholic steatohepatitis (Q42408750) (← links)
- Endoplasmic Reticulum Stress-induced Hepatocellular Death Pathways Mediate Liver Injury and Fibrosis via Stimulator of Interferon Genes. (Q51346281) (← links)
- Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actions. (Q52567489) (← links)
- Hypothalamus-Pituitary-Adrenal Dysfunction in Cholestatic Liver Disease (Q59335763) (← links)
- Crosstalk network among multiple inflammatory mediators in liver fibrosis (Q90205924) (← links)
- Deficient IL-6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis (Q92112798) (← links)
- Fermented ginseng, GBCK25, ameliorates steatosis and inflammation in nonalcoholic steatohepatitis model (Q92956295) (← links)